Alcor offering vitrification — nanotech not needed?

from the glass-not-ice dept.
sjvan writes "Alcor is now planning on vitrifying rather than freezing all new neurosuspension patients. This represents a major improvement in the quality of preservation, and consequently the probability of recovery. Look here for more details." CP: In that piece, Fred Chamberlain writes that this new procedure may eliminate the need for molecular nanotechnology in reviving these patients.